A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis

Abstract Background Antibiotics for the treatment of complicated, multidrug-resistant Gram-positive infections are limited, especially when prolonged treatment is necessary. Oritavancin is approved for the treatment of serious skin infections as a 1200 mg single-dose regimen, but case reports descri...

Full description

Saved in:
Bibliographic Details
Main Authors: Warren E. Rose (Author), Paul R. Hutson (Author)
Format: Book
Published: Adis, Springer Healthcare, 2020-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available